Our Portfolio

Tel Aviv University

Amos Korczyn, MD | Tel Aviv District, Israel

Project Overview

  • Academic/Nonprofit Organization Type
  • $160,000 Funding Amount
  • — 12/18/03 Project Duration
  • Drug Discovery Program
  • Status

Tel Aviv University

Amos Korczyn, MD | Tel Aviv District, Israel

A Phase II Trial to Determine the Effect of Aricept and Evoxac Combination Therapy on the Safety and Cognitive Function of Patients with Mild Alzheimer's Disease

GET IN TOUCH